Current Study: EQ

Purpose:
• To determine how an investigational drug is broken down and removed from the body in volunteers with liver impairment relative to volunteers with normal liver function
• Information regarding side effects that may occur will also be collected
• This study is for research purposes only and is not intended to treat your liver disease

Method of Administration: Single oral dose of the investigational drug

Investigator: Thomas Marbury, MD

To qualify:

• 18 to 75 years old
• Must have decreased liver function or disease such as fatty liver disease (NASH), hepatitis C (if successfully treated), past history of alcohol related liver disease or cirrhosis
• Volunteers may be taking medicines such as spironolactone, Lasix®, lactulose, Aldactone®, neomycin, or rifaximin
• May also have fluid in your abdomen, cirrhosis, or encephalopathy (brain condition that causes irritability or trouble sleeping

Length/Duration:
• Up to 6 days and 7 nights in our research facility
• 1 follow-up phone call

Location: 5055 South Orange Avenue, Orlando, FL 32809

Compensation: Qualified participants will receive the investigational drug, study related physical exams and laboratory tests

Qualified study participants will be compensated up to $2,550 for time and travel

Whom to Contact Recruitment Department: 407-240-7876